Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Practice of Molecular Radiotherapy

Tositumomab and 131I Therapy in Non-Hodgkin’s Lymphoma

Richard L. Wahl
Journal of Nuclear Medicine January 2005, 46 (1 suppl) 128S-140S;
Richard L. Wahl
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 46 no. 1 suppl 128S-140S
PubMed 
15653661

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online January 13, 2005.

Copyright & Usage 
THE JOURNAL OF NUCLEAR MEDICINE

Author Information

  1. Richard L. Wahl, MD
  1. Division of Nuclear Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
View Full Text

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: January 2005 to April 2025

AbstractFullPdf
Jan 200565239122
Feb 200555217125
Mar 20054216092
Apr 20053716475
May 20053113785
Jun 20053213957
Jul 2005198639
Aug 20052211034
Sep 2005187840
Oct 2005298734
Nov 2005369449
Dec 2005359048
Jan 2006152015
Feb 2006213737
Mar 2006143539
Apr 2006172017
May 200682726
Jun 200691928
Jul 200641715
Aug 200631714
Sep 200652318
Oct 200644224
Nov 200656731
Dec 200632827
Jan 200774325
Feb 200763634
Mar 200774744
Apr 2007126640
May 200742522
Jun 200764231
Jul 200792223
Aug 200783219
Sep 200745123
Oct 200785819
Nov 2007173616
Dec 2007102520
Jan 2008173525
Feb 2008103518
Mar 200874739
Apr 2008103334
May 2008113736
Jun 200862513
Jul 2008122914
Aug 2008143818
Sep 2008432613
Oct 2008393917
Nov 200853512
Dec 200811159
Jan 20092145
Feb 200981715
Mar 2009153938
Apr 2009141313
May 2009132417
Jun 200982410
Jul 20097188
Aug 200994022
Sep 200983427
Oct 2009192119
Nov 2009172123
Dec 200951017
Jan 201031619
Feb 2010201614
Mar 2010111917
Apr 201043119
May 2010101610
Jun 2010162314
Jul 201051710
Aug 2010331018
Sep 201017247
Oct 201081515
Nov 2010101812
Dec 2010161618
Jan 201192516
Feb 20111285
Mar 2011101722
Apr 201141921
May 20114219
Jun 2011221710
Jul 201121611
Aug 2011311321
Sep 2011411625
Oct 2011282029
Nov 2011351820
Dec 2011271516
Jan 2012431819
Feb 2012241723
Mar 2012411811
Apr 2012362119
May 2012432416
Jun 2012371713
Jul 2012231813
Aug 201226911
Sep 2012482016
Oct 2012311111
Nov 2012472223
Dec 2012311419
Jan 201343117
Feb 2013381813
Mar 201344169
Apr 2013291116
May 2013272114
Jun 201314818
Jul 20131228
Aug 201328912
Sep 2013151112
Oct 2013231413
Nov 2013181520
Dec 2013221710
Jan 20141455
Feb 201420510
Mar 201472118
Apr 2014181217
May 20141746
Jun 2014211111
Jul 201421189
Aug 201416209
Sep 201431286
Oct 201420226
Nov 2014482412
Dec 2014221411
Jan 2015302566
Feb 201512144
Mar 201529269
Apr 2015282111
May 2015202310
Jun 201515148
Jul 20157188
Aug 201521211
Sep 2015132413
Oct 201510112
Nov 201524196
Dec 2015262214
Jan 201629212
Feb 201625213
Mar 201618128
Apr 201612185
May 2016243415
Jun 201611337
Jul 201662519
Aug 2016162415
Sep 2016122813
Oct 2016102925
Nov 2016182412
Dec 201682715
Jan 201783616
Feb 2017122818
Mar 20178254
Apr 201714244
May 20178241
Jun 20178239
Jul 20178276
Aug 20177347
Sep 20177227
Oct 20174190
Nov 20178197
Dec 20177428
Jan 2018591
Feb 20185211
Mar 201842310
Apr 20185236
May 201883110
Jun 201823210
Jul 20183313
Aug 20181133
Sep 20180196
Oct 201811516
Nov 201861717
Dec 201881816
Jan 201931912
Feb 201922912
Mar 201984625
Apr 201963918
May 201941114
Jun 2019176
Jul 201932314
Aug 20192156
Sep 2019278
Oct 2019447
Nov 2019439
Dec 2019627
Jan 2020816
Feb 2020146
Mar 20201912
Apr 20201812
May 2020387
Jun 202041216
Jul 2020143
Aug 2020166
Sep 20205173
Oct 20207912
Nov 2020463
Dec 2020357
Jan 202132613
Feb 202151711
Mar 2021151
Apr 20214156
May 20216177
Jun 20211219
Jul 20211104
Aug 202124928
Sep 202119410
Oct 20211207
Nov 20215816
Dec 202151936
Jan 202251712
Feb 202222418
Mar 202241915
Apr 20225148
May 20223920
Jun 202231616
Jul 20222127
Aug 202231612
Sep 202211411
Oct 202261515
Nov 202242028
Dec 202282213
Jan 202341723
Feb 202351822
Mar 202342019
Apr 202331418
May 20235126
Jun 2023584
Jul 202331212
Aug 2023645
Sep 2023175
Oct 20239816
Nov 20231129
Dec 2023133612
Jan 202422113
Feb 20249912
Mar 202421518
Apr 202463019
May 2024193714
Jun 2024151643
Jul 202433422
Aug 202455020
Sep 202434015
Oct 2024102412
Nov 202426913
Dec 20245388
Jan 202532122
Feb 20251310213
Mar 202546117
Apr 2025105046
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 46 (1 suppl)
Journal of Nuclear Medicine
Vol. 46, Issue 1 suppl
January 1, 2005
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Tositumomab and 131I Therapy in Non-Hodgkin’s Lymphoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Tositumomab and 131I Therapy in Non-Hodgkin’s Lymphoma
Richard L. Wahl
Journal of Nuclear Medicine Jan 2005, 46 (1 suppl) 128S-140S;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Tositumomab and 131I Therapy in Non-Hodgkin’s Lymphoma
Richard L. Wahl
Journal of Nuclear Medicine Jan 2005, 46 (1 suppl) 128S-140S;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • CLINICAL RESULTS WITH TOSITUMOMAB AND 131I-TOSITUMOMAB THERAPY
    • CONCLUSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • The Costs to Our Patients
  • Biodistribution and Dosimetry of Indigenously Produced 131I-Rituximab in B-Cell Lymphoma: Pilot Study Estimating Patient-Specific Dose Comparing 2 Different Dosimetric Methods
  • Red Marrow-Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with 177Lu-Lilotomab Satetraxetan, a Novel Anti-CD37 Antibody-Radionuclide Conjugate
  • Study of the Impact of Tissue Density Heterogeneities on 3-Dimensional Abdominal Dosimetry: Comparison Between Dose Kernel Convolution and Direct Monte Carlo Methods
  • Differential Effects of Predosing on Tumor and Tissue Uptake of an 111In-Labeled Anti-TENB2 Antibody-Drug Conjugate
  • Arterial Wall Dosimetry for Non-Hodgkin Lymphoma Patients Treated with Radioimmunotherapy
  • Pretargeted Versus Directly Targeted Radioimmunotherapy Combined with Anti-CD20 Antibody Consolidation Therapy of Non-Hodgkin Lymphoma
  • Phase 1/2 study of fractionated 131I-rituximab in low-grade B-cell lymphoma: the effect of prior rituximab dosing and tumor burden on subsequent radioimmunotherapy
  • Therapeutic Potential of 90Y- and 131I-Labeled Anti-CD20 Monoclonal Antibody in Treating Non-Hodgkin's Lymphoma with Pulmonary Involvement: A Monte Carlo-Based Dosimetric Analysis
  • Essential Role of Nuclear Medicine Technology in Tositumomab and 131I-Tositumomab Therapeutic Regimen for Non-Hodgkin's Lymphoma.
  • Google Scholar

More in this TOC Section

  • Peptide Receptor Radionuclide Therapy for Non-Radioiodine-Avid Differentiated Thyroid Carcinoma
  • Dosimetry of Internal Emitters
  • Molecular Imaging as In Vivo Molecular Pathology for Gastroenteropancreatic Neuroendocrine Tumors: Implications for Follow-Up After Therapy
Show more Clinical Practice of Molecular Radiotherapy

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire